SIRAHAYDEE PENA-ALCANTARA: Open Payments
NPI 1033654678 · LAUDERHILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $987 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $153 |
| Novo Nordisk Inc | 4 | $86 |
| PFIZER INC. | 4 | $82 |
| Lilly USA, LLC | 3 | $59 |
| Exact Sciences Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Boston Scientific Corporation | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
Products named: LEQVIO, Ozempic, MOUNJARO, AIRSUPRA, ELIQUIS, XIFAXAN, The Cologuard Plus Collection Kit, WATCHMAN FLX.
Industry payments across FL — which companies pay providers there.
